These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8692969)

  • 21. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
    Liu CP; Bach FH; Wu SK
    J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spectrum of HLA-DQ and HLA-DR alleles, 2006: a listing correlating sequence and structure with function.
    Bondinas GP; Moustakas AK; Papadopoulos GK
    Immunogenetics; 2007 Jul; 59(7):539-53. PubMed ID: 17497145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
    J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-specific antibodies distinguish single amino acid substitutions in position 57 in HLA-DQ beta-chain alleles associated with insulin-dependent diabetes.
    Atar D; Dyrberg T; Michelsen B; Karlsen A; Kofod H; Mølvig J; Lernmark A
    J Immunol; 1989 Jul; 143(2):533-8. PubMed ID: 2738402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel human class II specificity, DQ "Wa," resides on DQ molecules of DR4,Dw15 and DRw8,Dw8 B-cell lines identified as DQ "blank".
    Endo T; Obata F; Ishikawa N; Kojima H; Kashiwagi N
    Hum Immunol; 1987 Nov; 20(3):209-17. PubMed ID: 3501781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
    J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic risk factors in inflammatory abdominal aortic aneurysms: polymorphic residue 70 in the HLA-DR B1 gene as a key genetic element.
    Rasmussen TE; Hallett JW; Metzger RL; Richardson DM; Harmsen WS; Goronzy JJ; Weyand CM
    J Vasc Surg; 1997 Feb; 25(2):356-64. PubMed ID: 9052571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
    Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
    J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease.
    Bugawan TL; Angelini G; Larrick J; Auricchio S; Ferrara GB; Erlich HA
    Nature; 1989 Jun; 339(6224):470-3. PubMed ID: 2498667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphic structural features of modelled HLA-DQ molecules segregate according to susceptibility or resistance to IDDM.
    Routsias J; Papadopoulos GK
    Diabetologia; 1995 Nov; 38(11):1251-61. PubMed ID: 8582533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific HLA-DQB and HLA-DRB1 alleles confer susceptibility to pemphigus vulgaris.
    Scharf SJ; Freidmann A; Steinman L; Brautbar C; Erlich HA
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6215-9. PubMed ID: 2503828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
    Marshall KW; Liu AF; Canales J; Perahia B; Jorgensen B; Gantzos RD; Aguilar B; Devaux B; Rothbard JB
    J Immunol; 1994 May; 152(10):4946-57. PubMed ID: 8176213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions.
    Buckner J; Kwok WW; Nepom B; Nepom GT
    J Immunol; 1996 Dec; 157(11):4940-5. PubMed ID: 8943399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase.
    Kwok WW; Domeier ML; Raymond FC; Byers P; Nepom GT
    J Immunol; 1996 Mar; 156(6):2171-7. PubMed ID: 8690906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alloreactive T cells can distinguish between the same human class II MHC products on different B cell lines.
    Santamaria P; Boyce-Jacino MT; Lindstrom AL; Rich SS; Faras AJ; Barbosa JJ
    J Immunol; 1991 Mar; 146(6):1822-8. PubMed ID: 1706381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
    McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
    J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DR beta chain residue 86 controls DR alpha beta dimer stability.
    Verreck FA; Termijtelen A; Koning F
    Eur J Immunol; 1993 Jun; 23(6):1346-50. PubMed ID: 8500529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule.
    van de Wal Y; Kooy YM; Drijfhout JW; Amons R; Papadopoulos GK; Koning F
    Immunogenetics; 1997; 46(6):484-92. PubMed ID: 9321428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.